GE HealthCare (GEHC.US) will acquire the remaining 50% stake in NMP to strengthen its radiopharmaceutical business.
GE HealthCare has agreed to acquire the remaining 50% stake in Nihon Medi-Physics (NMP) from Sumitomo Chemical.
GE HealthCare, Sumitomo Expect Agreement to Close in Early 2025 >GEHC
GE HealthCare Technologies to Acquire Remaining 50% Stake in Nihon Medi-Physics From Sumitomo Chemical >GEHC
Express News | GE Healthcare Technologies Inc - Transaction Expected to Be Neutral to Adjusted EPS in Year One
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, From Sumitomo Chemical
Express News | GE Healthcare to Acquire Remaining 50% Stake in Nihon Medi-Physics (Nmp), a Leading Radiopharmaceutical Company in Japan, From Sumitomo Chemical
Express News | Sumitomo Chemical: To Record 30 Bln Yen Gain in Other Operating Income Due to Transfer of Shares in Nihon Medi-Physics to Subsidiary of GE Healthcare Technologies
GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI
GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024
Peering Into GE HealthCare Techs's Recent Short Interest
10 Health Care Stocks With Whale Alerts In Today's Session
GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care
RadNet Unit Receives Expanded FDA Clearance for SmartMammo Mammography Software
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Is Largely Controlled by Institutional Shareholders Who Own 81% of the Company
GEHC Stock May Gain Following the Launch of Pristina Via System
Express News | GE Healthcare Unveils Pristina via to Streamline Technologist Workflow and Improve Patient-Centered Breast Care
GE HealthCare Unveils Pristina Via to Streamline Technologist Workflow and Improve Patient-centered Breast Care
Buy-rated Stocks With Passive and Active Net Buying Tailwinds – Citi
GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio
GE HealthCare Management to Present at Upcoming Investor Conferences